Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02313012 |
| Title | Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Celgene Corporation |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Cedars Sinai Medical Center, Inflammatory Bowel Disease Center | Los Angeles | California | 90048 | United States | Details | |
| Smilow Cancer Center | New Haven | Connecticut | 06510 | United States | Details | |
| Levine Cancer Institute | Charlotte | North Carolina | 28204 | United States | Details | |
| Sarah Cannon Cancer Center | Nashville | Tennessee | 37203 | United States | Details | |
| Peter MacCallum Cancer Centre | Melbourne | 3000 | Australia | Details |